Friday, 19 April, 2024
HomeCoronavirus

Coronavirus

One in five UK hospital patients caught COVID-19 while on wards — SAGE paper

Papers by UK government scientists have revealed that one in five hospital patients with coronavirus caught it while on wards, reports The Daily Telegraph....

Airborne transmission is dominant route for spread of COVID-19 — US analysis

A study by a team of researchers led by a Texas A&M University professor has found that not wearing a face mask dramatically increases...

Non-allergic asthma increases severe COVID-19 risk — Harvard study

Adults with asthma who became infected with the coronavirus that causes COVID-19 were at higher risk of developing severe illness compared with adults who...

Baldness 'a perfect predictor' of higher risk of severe COVID-19 – Research letter

Bald men may be at higher risk of suffering from severe COVID-19 symptoms, The Daily Telegraph reports emerging evidence suggests. The link is so...

Experimental drug to prevent COVID-19 blood clots — Imperial College trial

The British Heart Foundation is funding a trial for an experimental drug that could prevent the life-threatening blood clots that are seen in the...

ICL researchers begin human trials of a new coronavirus vaccine

Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London. The study...

COVID-19 antibodies may remain stable for two months after diagnosis

Initial results from an antibody testing study have revealed that COVID-19 antibodies remain stable in the blood of the majority of infected individuals almost...

Super-potent human antibodies protect against COVID-19 in animal tests — Scripps

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus...

Combo drug treatments for COVID-19 show promise in cell culture tests — Norway/Estonia study

Six months into the COVID-19 pandemic, more than 7.4m people have been infected, and more than 410,000 have died. As yet, there is no...

Novel alternative to PCR test diagnoses COVID-19 virus in 30 mins

A new diagnostic test can detect the RNA of SARS-CoV-2, the virus that causes COVID-19, in urine, blood, saliva or mouth swab samples in...

Self-swabbing tests for COVID-19 accurate and safe — Small Stanford study

Test samples collected by people who swabbed their own nasal passages yielded results for the COVID-19 virus that were as accurate as samples collected...

Mapping pandemic disease burden across US — Princeton

Per capita COVID-19 disease burden and healthcare system demand may be highest in rural areas in the US, according to a modelling study. These...

Potential approach to treating severe COVID-19 — US National Institutes of Health clinical study

Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients...

Remdesivir slows COVID-19 disease progression in macaques — US National Institutes of Health

Early treatment with the antiviral drug remdesivir is shown to reduce viral load and prevent lung disease in macaques infected with SARS-CoV-2, reports a...

Most-used COVID-19 test may miss 1 in 5 infections

The majority test for the novel coronavirus — a back of nose or throat swab using the RT-PCR laboratory procedure for genetic analysis —...

Hydroxychloroquine no better than placebo to prevent COVID-19 — First randomised clinical trial

University of Minnesota Medical School researchers have published the results from the first randomised clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19....

No clinical benefit from hydroxychloroquine in hospitalised COVID-19 patients — RECOVERY trial

A new statement has been released from the chief investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine. Professor Peter Horby...

Australian COVID-19 Clinical Evidence Taskforce recommends remdesivir for treatment

The antiviral drug remdesivir has been recommended for the treatment of COVID-19 patients in Australia, by the national taskforce bringing together the country’s peak...

Underlying illness risk factors for severe COVID-19 or death — Large UK cohort study

Age, male sex, obesity, and underlying illness have emerged as risk factors for severe COVID-19 or death in the UK, according to the largest...

Kawasaki-like syndrome more common among children of African ancestry — Small French study

An inflammatory syndrome in children and adolescents, believed to be linked to COVID-19, seems to be more common among children of African ancestry, finds...

Coronavirus linked to stroke in otherwise healthy young people — Small US observational study

Young patients with no risk factors for stroke may have an increased risk if they have contracted COVID-19, whether or not they are showing...

COVID-19 outbreak lasts 2.4 days longer for each day's delay in social distancing

Epidemiological researchers at The University of Texas at Austin, Dalian Minzu University, University of Cambridge, University of Hong Kong and Yale School of Public...

Early evidence of pronounced brain involvement in fatal COVID-19 outcomes — 6 autopsies

The first cases of COVID-19 in Germany were confirmed in the greater Munich area and isolated in our hospital. Subsequently, more than 690 patients...

Different blood biomarkers could predict COVID-19 disease progression

Researchers from Charité-Universitätsmedizin Berlin and the Francis Crick Institute have identified 27 proteins which are present at different levels in the blood of COVID-19...

Evidence supports physical distancing, masks, and eye protection — WHO commissioned meta-analysis

A comprehensive review of existing evidence supports physical distancing of two metres or more to prevent person-to-person transmission of COVID-19, says an international team...

How lockdown altered SARS-Ccov-2 transmission in Europe — 11-country modelling study

Large-scale lockdowns and other non-pharmaceutical interventions in Europe have been successful in reducing the transmission levels of SARS-CoV-2 enough to control the epidemic growth,...

Assessing effect of anti-contagion policies on COVID-19 pandemic — 6-nation analysis

The effects of large-scale anti-contagion policies, such as lockdowns and travel restrictions, that have been implemented by governments to slow down the rate of...

Arthritis drug may be efficacious with COVID-19 — Small French retrospective cohort study

French doctors administered anakinra, an anti-inflammatory drug normally used to treat rheumatoid arthritis, to 52 COVID-19 patients at the Saint-Joseph Public Hospital in Paris...

One in 10 diabetes patients with COVID-19 dies within 7 days — French CORONADO study

The first study of COVID-19 to specifically analyse the effect of the disease in hospitalised patients with diabetes has found that one in ten...

Even mild coronavirus infection leads to antibodies — Pasteur Institute

A medical study in France suggests even mild cases of coronavirus infection, not requiring hospital treatment, produce antibodies in almost all patients, with the...

Cancer patients with COVID-19 have 13% death rate — CC19 first report

People with cancer sickened by COVID-19 have a crude death rate of 13%, according to the largest series of data released thus far from...

Public disclosure of COVID-19 more effective than lockdowns — NBER working paper

The COVID-19 outbreak was identified in both South Korea and in the US on 13 January. As of 22 May, South Korea had 11,142...

'Vast majority’ with COVID-19 are asymptomatic — UK's Office of National Statistics

The vast majority of people who contract coronavirus never show any symptoms, The Daily Telegraph reports the first analysis of antibody tests by the...

CORONA inventory of drugs being used to treat COVID-19

With doctors and researchers around the world searching for effective treatments for COVID-19, many drugs approved to treat other diseases are being used in...

Vitamin D supplementation: No benefit in preventing/treating COVID-19 — Consensus paper

Scientists from the UK, Europe and the US, including experts from the University of Birmingham, have published a vitamin D consensus paper warning against...

COVID-19 patients undergoing surgery at increased risk of post-operative death — NIHR

Patients undergoing surgery after contracting coronavirus are at greatly increased risk of post-operative death, a global study reveals. Researchers found that amongst SARS-CoV-2 infected...

Characteristics of ischaemic stroke associated with COVID-19 — American Heart Association

In a study, researchers have reported key demographic and clinical characteristics of patients who developed ischaemic stroke associated with the COVID-19 infection and received...

Using riboflavin, UV light reduces SARS-CoV-2 pathogens in plasma/whole blood

Scientists do not yet know if SARS-CoV-2 – the virus that causes COVID-19 – can be transmitted by blood transfusion. But given the unknowns...

COVID-19 far deadlier than the flu — University of Washington analysis of 116 counties

COVID-19 is a lot more deadly than the flu, concludes a study by the University of Washington. The study's results also project a grim future if...

Evidence review shows cloth masks may reduce COVID-19 transmission

The evidence shows that cloth masks, particularly those with several layers of cotton cloth, block droplet and aerosol contamination of the environment, which may...